Press Release: Affimed Announces Closing of Public Offering of Common Shares and Full Exercise of Underwriters' Option to Purchase Additional Shares
(2) Press Release: Affimed Announces Closing of Public Offering of Common Shares and Full Exercise of Underwriters Option to Purchase Additional Shares Heidelberg, Germany, January 15, 2021 -- Affimed N.V. ("Affimed" or the "Company") (Nasdaq: AFMD), a clinical stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced the closing of its previously announced public offering of 16,666,667 common shares, at the public offering price o...
Source: finanznachrichten.de